Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Synordia European application withdrawn

Dec. 12, 2006

Positive findings for Nastech's insulin nasal spray formulations

Dec. 12, 2006

PRTX-100 inhibits platelet phagocytosis in an in vitro model of ITP

Dec. 12, 2006

Emergency contraceptive Ella begins phase III study

Dec. 12, 2006

Xenon and Roche partner on protein therapeutics targeting hemojuvelin

Dec. 12, 2006

Eltrombopag studied for ITP in long-term phase III study

Dec. 12, 2006

Nastech updates status of PTH1-34 Nasal Spray program

Dec. 11, 2006

PhytoMedical to expedite development of polyphenolic compounds for diabetes

Dec. 11, 2006

Novel bioactive natural products presented at the Medicinal Chemistry Symposium

Dec. 11, 2006

Study provides clues on the hypoglycemic action of novel KATP channel modulator

Dec. 11, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...